/
RXST
$5.10-$0.26 (-4.85%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$221.9M
41M shares
52-week range
$4.48 – $13.65
7% from low
Sector
OPHTHALMIC GOODS
Exchange
NASDAQ
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-10.90
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $14.7M | $22.6M | $49.0M | $89.1M | $139.9M | $134.5M |
| Cost of revenue | $4.1M | $13.0M | $18.1M | $27.7M | $35.3M | $41.0M | $31.5M |
| Gross profit | −$1.8M | $1.7M | $4.5M | $21.3M | $53.8M | $98.9M | $103.0M |
| Gross margin | -81.2% | 11.6% | 20.0% | 43.5% | 60.4% | 70.7% | 76.6% |
| R&D | $29.6M | $21.9M | $24.5M | $26.0M | $29.1M | $34.4M | $38.5M |
| Operating income | −$46.1M | −$35.4M | −$52.8M | −$63.3M | −$50.1M | −$36.9M | −$48.2M |
| EBITDA | $130.2M | $32.2M | −$41.0M | −$57.8M | −$41.0M | −$23.8M | −$38.8M |
| Net income | $126.2M | $27.6M | −$48.7M | −$66.8M | −$48.6M | −$27.5M | −$38.9M |
| Net margin | 5632.3% | 187.9% | -215.5% | -136.2% | -54.6% | -19.6% | -29.0% |
| EPS (diluted) | 6.62 | 0.18 | -1.78 | -2.41 | -1.41 | -0.71 | -0.95 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $129M | $-1.42 | $-1.55–$-1.27 | 5 |
| 2027 | $142M | $-1.28 | $-1.47–$-1.10 | 5 |
| 2028 | $155M | $-1.19 | $-1.35–$-1.00 | 5 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
RxSight, Inc. Common Stock
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
www.rxsight.com- Employees
- 461
- IPO / List date
- Jul 30, 2021
- HQ
- ALISO VIEJO, CA
Held by traders on TradeandTell
No one on the platform currently holds RXST.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 60,400 | $372.1K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2006-09-21 | 9-for-1 |
Recent trades on TradeandTell
No one on the platform has traded RXST yet.
